1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Global Refractive Surgery Devices Market By Application, By Product, By End Use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

Global Refractive Surgery Devices Market By Application, By Product, By End Use, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • September 2021
  • 229 pages
  • ID: 6177781
  • Format: PDF
  • KBV Research


Table of Contents

The Global Refractive Surgery Devices Market size is expected to reach $331.5 billion by 2027, rising at a market growth of 9.4% CAGR during the forecast period. Refractive surgery is also known as vision correction surgery or laser surgery, which helps in correcting eyesight problems. The Refractive surgery technique is used to give structural changes to the eyes and to improve the refractive status of the patient’s eye. The best treatment needed for chronic eye disorders is the surgeries involved in ophthalmology practice. These surgeries assist in the correction of vision and treatment of other ocular disorders, which can further lead to blindness. The kind of surgery devices to be used depends on the kind of eye disorder the patient is suffering from.

The demand for refractive surgeries is anticipated to increase, attributed to the rise in the number of aging population and excessive use of digital devices, which has increased the screen time of the world population due to the COVID-19 pandemic. As per the study by JAMA Ophthalmology, during the pandemic, a major eye problem recorded among the youngsters is myopia, due to the increased screen time. Also, by WHO, Myopia is the major issue, which is rising constantly and it is anticipated that more than half of the population will get affected by this chronic eye disease in the upcoming years. In addition, the high possibilities of developing refractive errors are among the geriatric population and will be needed immediate treatment to correct this eye problem.

COVID-19 Impact

The outbreak of the COVID-19 pandemic, has a negative impact on the various industries, leading to the decline in the productivity of the businesses. During this pandemic, customers started spending their time more on digital devices, which is therefore responsible to have a great effect on the eyes. The organizations started to continue their business through the online platform, also a new trend of working from home emerged, which has increased the cases of dry eye, myopia, and eyestrain. In addition, the increase in the geriatric population has driven the demand for refractive surgery equipment.

The COVID-19 pandemic led to restrictive controlling measures including remote working, social distancing, and hindrance in commercial activities. In contrast, the refractive surgery devices market is anticipated to increase in the upcoming years. This is due to the organization’s rearrangement in their operations and is getting better from the impact of COVID-19. The refractive surgery equipment market includes sales of refractive surgery devices. As there is a rise in the number of patients suffering from eye problems, the demand for surgical devices is boosting, and therefore, it would augment the growth of the refractive surgery devices market.

Market Growth Factors:

Rising number of advanced technologies offering lucrative opportunities

The demand for the latest technologies is increasing with the evolving time. In the healthcare sector also, there is need for advanced technologies to make improvements in treatment and surgeries. For correction of refractive errors in the eyes, doctors use refractive surgery. This increment in the advanced technologies helps in increasing the efficiency of the devices by reducing the risks of error. All these factors are accountable to push the growth of the refractive surgery devices market.

Achievements of LASIK surgeries helping in expanding the market

The objective of refractive surgery is to improve or correct the patient’s refractive error of the eye. The commonly performed refractive surgery is the Laser-Assisted in Situ Keratomileusis (LASIK). It is performed to treat astigmatism, hyperopia, and myopia. The LASIK surgery reduces or eliminates the use of contact lenses or glasses by allowing the light to directly focus on the retina. This is attained by reshaping the cornea of the eye.

Market Restraining Factor:

Lack of training among the doctors to operate the advanced technologies

Operating advanced refractive surgery devices in the healthcare sector require skilled eye specialist. The highly technical operations of these surgeries create challenges for any regular doctor to operate these devices and thus, need special training for it. However, the shortage of ophthalmologists decreases the number of testings, mainly in the developing regions, and hence, hampering the demand for refractive surgery devices in the market.

Application Outlook

Based on Application, the market is segmented into Astigmatism, Myopia, Hyperopia, Presbyopia, and Dry eyes. Myopia acquired the maximum revenue share in 2020 and would witness a gradual growth rate over the forecast years. Myopia is increasing worldwide at an extreme level along with a substantial rise in the chances of vision impairment. As stated by WHO, nations experiencing the occurrence of myopia or slowly increase in the number of cases are expected to significantly increase during the forecast period.

Product Outlook

Based on Product, the market is segmented into Lasers, Microkeratome, Aberrometers and Other Products. The lasers segment obtained the maximum revenue share in 2020 due to the upsurge in the utilization of laser surgeries for correcting vision and improvements in technologies. The laser segment is anticipated to display the fastest growth rate over the forecast period. The demand for laser refractive surgeries like LASIK, LASEK, and PRK is excessively increasing. This surge is due to the significant decline in the adoption of contact lenses or eyeglasses and the high success rate of refractive surgery.

End Use Outlook

Based on End Use, the market is segmented into Ophthalmology Clinics, Hospitals and Ambulatory surgery centers. Ambulatory surgical centers segment would witness the fastest growth rate over the forecast years. The surgical centers are getting popular among the population as they are convenient to reach and have low charges for patients and insurance. Also, these centers are more convenient in scheduling dates for surgery than hospital OPDs. Though, it is anticipated that this factor would propel the growth of the segment.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia-Pacific is projected to display the maximum growth rate over the forecast years. As reported by World Health Organization, there is a large number of cases of myopia in economically strong nations. The demand for refractive surgery equipment is surged by the evolving environmental conditions and lifestyles like an aging population, maximum utilization of computers & phones, and air pollution. Various western organizations are taking advantage of the growing need for ophthalmic equipment in Asia.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Johnson & Johnson and Novartis AG are the forerunners in the Refractive Surgery Devices Market. Companies such as Carl Zeiss Meditec AG, and Topcon Corporation are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).

Recent Strategies Deployed in Refractive Surgery Devices Market

Partnerships, Collaborations, and Agreements:

Jun-2021: Glaukos Corporation received regulatory approval by the Therapeutic Goods Administration (TGA) of Australia for PRESERFLO MicroShunt. PRESERFLO MicroShunt aimed to decrease intraocular pressure (IOP) in eyes of patients with primary open-angle glaucoma where IOP would remain uncontrollable along with being the maximum tolerated medical therapy and/or where glaucoma progression warrants surgery.

Jun-2021: Bausch + Lomb signed an agreement with Lochan, a company in the Information Technology Services Industry. Together, the companies aimed to develop the next generation of Bausch + Lomb’s eyeTELLIGENCE clinical decision support software. By utilizing the prevailing cloud-based infrastructure of eyeTELLIGENCE, this software would be developed to enable surgeons to effortlessly combine all factors of the cataract, retinal and refractive surgery procedures to optimize their total practice efficiency.

May-2021: Glaukos Corporation signed a new development and commercialization license agreement with Santen Pharmaceutical Co. In this agreement, Glaukos got the exclusive commercialization rights for the MicroShunt in Australia, the United States, Mexico, New Zealand, Brazil, Canada, and the rest of Latin America. This new agreement also gave Glaukos full control on all the development activities for the MicroShunt in these same areas that include all clinical development & regulatory affairs activities in the US following a transition period.

Mar-2021: Topcon signed an agreement with Iridex, provider of an array of established laser procedures. Under this agreement, Iridex would join Topcon’s comprehensive distribution network across the Asia Pacific and key EMEA regions, which would assist Iridex to considerably expand the market penetration of its marquee non-incisional glaucoma therapy. In addition, Iridex would also acquire the Pascal line from Topcon to integrate its MicroPulse technology and the Pascal laser platform.

Apr-2021: Glaukos Corporation signed an amended licensing agreement with Intratus, a privately held, clinical-stage life sciences company. Under this agreement, Glaukos got the global exclusive license to develop research, commercialize and manufacture Intratus’ patented, non-invasive drug delivery platform for application in the treatment of presbyopia.

Acquisitions and Mergers:

Jul-2021: Topcon completed the acquisition of Italian ophthalmic device maker VISIA Imaging. This acquisition aimed to improve Topcon’s development and manufacturing offering of anterior segment devices & software that would support the company’s portfolio of posterior segment imaging devices, which consist of fundus cameras and optical coherence tomography.

Mar-2021: EssilorLuxottica acquired Walman, provider of optical products. This acquisition aimed to enable EssilorLuxottica’s customers to leverage prevailing and future opportunities to grow the market. In addition, Walman has a network of 35 facilities in the U.S., which include prescription lens-finishing labs & hubs for optical instruments and other vision care products. Under this acquisition, Walman would continue to serve the market in the name of the Walman brand.

Product Launches and Product Expansions:

Jul-2021: Johnson & Johnson Vision launched the VERITAS Vision System, next-generation phacoemulsification (phaco) system. This system is developed to look after three important areas: surgeon efficiency, patient safety, and comfort.

Mar-2021: NIDEK unveiled RT-6100 CB for Windows, optional control software for the RT-6100 Intelligent Refractor, and the TS-610 Tabletop Refraction System. This software adapts to the specific requirements of patients and operators. In addition, the software enables refractions, which fulfill social distancing requirements.

May-2020: Bausch + Lomb introduced the company’s first presbyopia-correcting intraocular lens (IOL), LuxSmart, and its monofocal version, LuxGood. Both the product includes a hydrophobic material and showcases the release of the latest platform for Bausch + Lomb, making a part of a whole range of innovative IOLs, they also feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology.

Scope of the Study

Market Segments covered in the Report:

By Application

• Astigmatism

• Myopia

• Hyperopia

• Presbyopia, and

• Dry eyes

By Product

• Lasers

• Microkeratome

• Aberrometers and

• Other Products

By End Use

• Government

• Energy

• Defense

• Agriculture & Forestry

• Media & Entertainment

• Civil Engineering & Archaeology

• Others

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific


o Brazil

o Argentina


o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Carl Zeiss Meditec AG

• Topcon Corporation

• Novartis AG

• Glaukos Corporation

• Johnson & Johnson

• EssilorLuxottica SA

• Bausch Health Companies, Inc.

• SCHWIND Eye-Tech-Solutions GmbH


• Quantel Medical (Lumibird Group)

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Surgical Microscopes Market - A Global and Regional Analysis: Focus on Product Type, Application, End User, 25 Countries’ Data, Patent Scenario, and Competitive Landscape - Analysis and Forecast, 2021-2031

  • $ 5250
  • November 2021
  • 157 pages

Global Surgical Microscopes Market to Reach $3,578.2 Million by 2031 Market Report Coverage - Surgical Microscopes Market Segmentation • Product Type – Conventional Microscopes and Advanced Microscopes • ...

  • World
  • North America
  • Healthcare
  • Neurology
  • Industry analysis


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on